SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-16-000170
Filing Date
2016-05-04
Accepted
2016-05-04 06:07:16
Documents
3
Period of Report
2016-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ligand-8xk_q116earningsrel.htm 8-K 26231
2 EXHIBIT 99.1 q12016earningsrelease10-q.htm EX-99.1 187514
3 ligandlogoa07.jpg GRAPHIC 36525
  Complete submission text file 0000886163-16-000170.txt   265344
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 161617307
SIC: 2834 Pharmaceutical Preparations